Harrow Health

HROW

Harrow Health, formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company (NASDAQ: HROW) based in Nashville, TN. The change of name to Harrow Health in January 2019 reflected a goal of "creating, investing in, operating and growing a diversified portfolio of health care …

Insider trades and stock quote 2024-2026

All insider trades at Harrow Health

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/14/2026 Sell Shojaei, Amir CHIEF SCIENTIFIC OFFICER $40.0 $450,000
5/18/2026 Buy Silvernail, Lauren P. Director $31.0 $31,000
5/18/2026 Buy Graves, Adrienne L. Director $31.1 $31,070
5/14/2026 Buy Boll, Andrew R. PRESIDENT AND CFO $29.9 $104,650
5/14/2026 Buy Baum, Mark L. CHIEF EXECUTIVE OFFICER $30.2 $302,000
3/4/2026 Sell Opaleye Management Inc. Ten Percent Owner $39.7 $5,485,183
3/3/2026 Sell Opaleye Management Inc. Ten Percent Owner $39.2 $2,361,242
2/27/2026 Sell Opaleye Management Inc. Ten Percent Owner $54.2 $270,900
1/6/2026 Sell Opaleye Management Inc. Ten Percent Owner $53.3 $1,066,914
6/10/2025 Sell Opaleye Management Inc. Ten Percent Owner $30.8 $462,033
6/9/2025 Sell Opaleye Management Inc. Ten Percent Owner $30.4 $461,794
6/4/2025 Sell Opaleye Management Inc. Ten Percent Owner $30.0 $53,907
6/3/2025 Sell Opaleye Management Inc. Ten Percent Owner $30.0 $90,116
5/13/2025 Sell Opaleye Management Inc. Ten Percent Owner $26.6 $132,945
5/12/2025 Sell Opaleye Management Inc. Ten Percent Owner $25.9 $258,959
3/24/2025 Sell Opaleye Management Inc. Ten Percent Owner $30.0 $150,055
3/18/2025 Sell Opaleye Management Inc. Ten Percent Owner $29.8 $446,455
2/28/2025 Sell Opaleye Management Inc. Ten Percent Owner $28.0 $140,250
1/22/2025 Sell Opaleye Management Inc. Ten Percent Owner $35.6 $711,814
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)